Shawn McCormick

Insider profile

Currently holds positions in Nevro Corp, Surmodics Inc and Inspire Medical Systems, Inc.

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 95% 68% 82%
Transactions
7 14% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Nevro Corp Sept. 1, 2014 -
Independent Director Surmodics Inc Dec. 18, 2015 -
Independent Director Inspire Medical Systems, Inc. Jan. 1, 2017 -
Independent Director Entellus Medical Inc Nov. 1, 2014 - Feb. 28, 2018
Chief Financial Officer Wright Medical Group NV Sept. 4, 2012 - Oct. 1, 2015
Shawn McCormick's trades of Inspire Medical Systems, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
306.21
Quantity 65,672 -23.2%
Value US$4,810,674
Transaction date
Proposed sale
Price
213.70
Quantity 88,167
Value US$2,376,804
Transaction date
Sale
Price
439.27
Quantity 90,543 +22.8%
Value US$49,071
Transaction date
Proposed sale
Price
126.34
Quantity 1,200
Value US$151,608
Transaction date
Sale
Price
127.48
Quantity 2,000 -7.1%
Value US$254,960
Transaction date
Proposed sale
Price
127.33
Quantity 2,000
Value US$254,660
Transaction date
Proposed sale
Price
157.90
Quantity 360
Value US$56,844
Transaction date
Proposed sale
Price
220.00
Quantity 800
Value US$176,000
US Nevro Corp (NVRO)
Transaction date
Purchase
Price
22.88
Quantity 7,500 +38.7%
Value US$171,633
US Nevro Corp (NVRO)
Transaction date
Planned sale
Price
149.65
Quantity 482 -6.2%
Value US$72,131
Transaction date
Sale
Price
0.03
Quantity 1,329,186
Value £39,876
US Nevro Corp (NVRO)
Transaction date
Planned sale
Price
126.50
Quantity 1,020 -11.6%
Value US$129,030
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-11 2026-05-08
S Sale
65,672 -23.2%
306.21
US$4,810,674 		65,672 -23.2% 306.21 US$4,810,674
2026-05-08 2026-05-08
PrS Proposed sale
88,167
213.70
US$2,376,804 		88,167 213.70 US$2,376,804
2025-12-04 2025-12-02
S Sale
90,543 +22.8%
439.27
US$49,071 		90,543 +22.8% 439.27 US$49,071
2025-12-02 2025-12-02
PrS Proposed sale
1,200
126.34
US$151,608 		1,200 126.34 US$151,608
2025-12-01 2025-11-28
S Sale
2,000 -7.1%
127.48
US$254,960 		2,000 -7.1% 127.48 US$254,960
2025-11-28 2025-11-28
PrS Proposed sale
2,000
127.33
US$254,660 		2,000 127.33 US$254,660
2025-05-05 2025-05-02
S Sale
360 -1.5%
160.00
US$57,600 		360 -1.5% 160.00 US$57,600
2025-05-02 2025-05-02
PrS Proposed sale
360
157.90
US$56,844 		360 157.90 US$56,844
2024-09-11 2024-09-09
S Sale
800 -3.3%
220.00
US$176,000 		800 -3.3% 220.00 US$176,000
2024-09-09 2024-09-09
PrS Proposed sale
800
220.00
US$176,000 		800 220.00 US$176,000
2023-06-09 2023-06-07
US Nevro Corp (NVRO)
B Purchase
7,500 +38.7%
22.88
US$171,633 		7,500 +38.7% 22.88 US$171,633
2021-05-26 2021-05-24
US Nevro Corp (NVRO)
PlS Planned sale
482 -6.2%
149.65
US$72,131 		482 -6.2% 149.65 US$72,131
2020-06-30 2020-06-30
S Sale
1,329,186
0.03
£39,876 		1,329,186 0.03 £39,876
2020-05-26 2020-05-21
US Nevro Corp (NVRO)
PlS Planned sale
1,020 -11.6%
126.50
US$129,030 		1,020 -11.6% 126.50 US$129,030